HilleVax: Takeda’s Norovirus Vaccine Spinout (NASDAQ:HLVX)
Natali_Mis/iStock via Getty Images Certain medicines are so widely necessary that it is impossible to charge too much for them. Antibiotics and vaccines fall under this class. I never buy vaccine stocks, barring the rare exception, because I believe ROI may be poor for such companies. With that caveat, let us dig into HilleVax (NASDAQ:HLVX),…